Diagnostic value of pleural effusion for the detection of EGFR in NSCLC: a meta-analysis

l. yang (Chengdu, China), P. Tian (Chengdu, China), W. Li (Chengdu, China)

Source: International Congress 2019 – Diagnosis of lung cancer
Session: Diagnosis of lung cancer
Session type: Thematic Poster
Number: 3063
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
l. yang (Chengdu, China), P. Tian (Chengdu, China), W. Li (Chengdu, China). Diagnostic value of pleural effusion for the detection of EGFR in NSCLC: a meta-analysis. 3063

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Diagnostic value and prognostic significance of pleural C-reactive protein in lung cancer with malignant pleural effusions
Source: Annual Congress 2012 - Instructive clinical aspects of thoracic oncology
Year: 2012

Diagnostic and prognostic significance of survivin levels in malignant pleural effusion
Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions
Year: 2011

Diagnostic utility of pleural CEA and CYFRA 21-1 for malignant pleural effusions
Source: Eur Respir J 2003; 22: Suppl. 45, 60s
Year: 2003

Diagnostic usefulness of tumour markers in pleural effusions
Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Year: 2009


Diagnostic value of common MAGE RT-PCR in malignant pleural effusion
Source: Eur Respir J 2002; 20: Suppl. 38, 273s
Year: 2002

Diagnostic thoracoscopy in patients with lung cancer and pleural effusion
Source: Annual Congress 2007 - Pleural techniques and diagnosis of peripheral lung nodules
Year: 2007


Diagnostic utility of cell block method combined with conventional smear cytology in the diagnosis of exudative pleural effusions accompanying lung cancer
Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases
Year: 2013


Prognostic significance of serum and pleural mesothelin in malignant pleural mesothelioma (MPM)
Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Year: 2017

A prospective trial evaluating the role of mesothelin in undiagnosed pleural effusions
Source: Eur Respir J 2013; 41: 18-24
Year: 2013



Survival of lung adenocarcinoma patients with malignant pleural effusion
Source: Eur Respir J 2013; 41: 1409-1418
Year: 2013



Diagnostic value of pleural fluid angiopoietin-2 (Ang-2) levels, to differentiate malignant pleural effusions from benign pleural effusions
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016

Diagnostic significance of ADAM8 in non-small cell lung cancer and malignant pleural effusion
Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology
Year: 2008

Diagnostic value of combined assays in differentiating tuberculous and malignant pleural effusions
Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis
Year: 2008


Prognostic significance of pleural tumour burden in patients with malignant pleural effusions
Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement?
Year: 2010


The diagnostic value of CA-125 in pleural effusions
Source: Eur Respir J 2001; 18: Suppl. 33, 386s
Year: 2001

Diagnostic value of detection of promoter hypermethylation of tumor suppressor genes in pleural fluid for diagnosis of malignant pleural effusion
Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach
Year: 2010


Utility of pleural fluid for predictive marker testing in malignant pleural effusion
Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications
Year: 2020



Detection of mesothelin in the pleural effusion has a higher diagnostic utility than in serum for diagnostic of malignant mesothelioma
Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies
Year: 2013

Clinical usefulness of the novel drug sensitivity test for malignancy using pleural effusion
Source: Annual Congress 2006 - Lung cancer biology and chemosensitivity
Year: 2006


Clinical significance of CEA, NSE, CYFRA 21-1 in serum and pleural fluid for the diagnosis of malignant pleural effusion associated with primary lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 528s
Year: 2004